1 – 15 of 29
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- Two-step production of monoamines in monoenzymatic cells in the spinal cord : A different control strategy of neurotransmitter supply? (
- 2014
- Novel strategies for enzyme replacement with gene therapy in models of Parkinson’s disease (
- 2012
- Dysregulated dopamine storage increases the vulnerability to alpha-synuclein in nigral neurons (
- Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain (
- 2010
- Modeling pathophysiological aspects of Parkinson’s disease: Manipulating DA handling and alpha-synuclein expression in the nigrostriatal pathway using viral vectors (
- 2009
- Gene therapy by enzyme replacement for Parkinson’s disease Optimization of continuous DOPA delivery and development of a candidate vector for clinical application (
- Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats (
- Positron Emission Tomography Imaging Demonstrates Correlation between Behavioral Recovery and Correction of Dopamine Neurotransmission after Gene Therapy (
- 2007
- Cell and Gene Therapy for Parkinson's Disease: Therapeutic Effect and Modulation of Dyskinesias in the 6-OHDA Rat Model (
- 2006
- Induction of dopaminergic neurons from growth factor expanded neural stem/progenitor cell cultures derived from human first trimester forebrain. (
- Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. (
- 2005
- Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. (
- Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors. (
- Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. (
- 2004
- GDNF gene delivery in an animal model of Parkinson's disease. Long-term effects on intact, injured and transplanted dopamine neurons using lentiviral gene transfer (